We are live on ! Find out more
ICCM icon

IceCure Medical
ICCM

15 hedge funds and large institutions have $118K invested in IceCure Medical in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

7% more funds holding

Funds holding: 14 → 15 (+1)

0.01% less ownership

Funds ownership: 0.03% → 0.01% (-0.01%)

56% less capital invested

Capital invested by funds: $268K → $118K (-$150K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$40.5K
2
XT
XTX Topco
Cayman Islands
+$17.8K
3
HF
HRT Financial
New York
+$9.13K
4
AW
Avion Wealth
Texas
+$1.69K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$125K
2
Renaissance Technologies
Renaissance Technologies
New York
-$49.1K
3
KFG
Kingdom Financial Group
Arizona
-$12.6K
4
VF
Virtu Financial
New York
-$8.52K
5
Two Sigma Investments
Two Sigma Investments
New York
-$1.85K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$36.5K +$40.5K +1,996 New
XT
2
XTX Topco
Cayman Islands
$16.1K +$17.8K +877 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$15.6K – – –
Two Sigma Investments
4
Two Sigma Investments
New York
$11.3K -$1.85K -91 -13%
VF
5
Virtu Financial
New York
$9K -$8.52K -420 -46%
HF
6
HRT Financial
New York
$8K +$9.13K +450 New
CIA
7
Concurrent Investment Advisors
Florida
$6.1K – – –
FIA
8
Foundations Investment Advisors
Arizona
$6.1K – – –
Morgan Stanley
9
Morgan Stanley
New York
$3.7K – – –
JP Morgan Chase
10
JP Morgan Chase
New York
$3.63K – – –
AW
11
Avion Wealth
Texas
$1K +$1.69K +83 New
Bank of America
12
Bank of America
North Carolina
$526 – – –
TRCT
13
Tower Research Capital (TRC)
New York
$179 – – –
BCWM
14
Bartlett & Co Wealth Management
Ohio
$153 – – –
Citadel Advisors
15
Citadel Advisors
Florida
– -$125K -5,650 Closed
Renaissance Technologies
16
Renaissance Technologies
New York
– -$49.1K -2,213 Closed
KFG
17
Kingdom Financial Group
Arizona
– -$12.6K -567 Closed

ICCM Hedge Fund Activity: Q3 2024 in Review

15 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q3 2024, worth a combined $118K — down 56% from $268K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new ICCM positions and 3 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $40.5K. The largest seller was Citadel Advisors, exiting entirely with an estimated $125K sold.

  • 15 institutional investors held IceCure Medical (ICCM) as of Q3 2024, up from 14 in Q2 2024.
  • Funds reported $118K of IceCure Medical stock for Q3 2024, down 56% quarter-over-quarter.
  • 4 funds opened new IceCure Medical positions in Q3 2024 and 3 closed out, a net change of +1 holder.
  • The largest IceCure Medical buyer in Q3 2024 was UBS Group, an estimated $40.5K added.
  • The largest IceCure Medical seller in Q3 2024 was Citadel Advisors, an estimated $125K sold.

Based on aggregated 13F filings for Q3 2024.